company background image
688098 logo

Shanghai Shen Lian Biomedical SHSE:688098 Stock Report

Last Price

CN¥4.12

Market Cap

CN¥1.7b

7D

0%

1Y

-45.1%

Updated

14 Jul, 2024

Data

Company Financials

Shanghai Shen Lian Biomedical Corporation

SHSE:688098 Stock Report

Market Cap: CN¥1.7b

688098 Stock Overview

Engages in the research, development, production, and sale of veterinary biological products in China.

688098 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends1/6

Shanghai Shen Lian Biomedical Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Shen Lian Biomedical
Historical stock prices
Current Share PriceCN¥4.12
52 Week HighCN¥8.13
52 Week LowCN¥3.86
Beta0.64
11 Month Change-7.83%
3 Month Change-16.09%
1 Year Change-45.07%
33 Year Change-68.93%
5 Year Changen/a
Change since IPO-88.81%

Recent News & Updates

Recent updates

Shanghai Shen Lian Biomedical Corporation's (SHSE:688098) Popularity With Investors Is Under Threat From Overpricing

Apr 15
Shanghai Shen Lian Biomedical Corporation's (SHSE:688098) Popularity With Investors Is Under Threat From Overpricing

Shareholder Returns

688098CN PharmaceuticalsCN Market
7D0%-0.6%1.2%
1Y-45.1%-15.3%-18.5%

Return vs Industry: 688098 underperformed the CN Pharmaceuticals industry which returned -15.3% over the past year.

Return vs Market: 688098 underperformed the CN Market which returned -18.5% over the past year.

Price Volatility

Is 688098's price volatile compared to industry and market?
688098 volatility
688098 Average Weekly Movement6.8%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.0%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 688098's share price has been volatile over the past 3 months.

Volatility Over Time: 688098's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001380Xu Gaowww.slbio.com.cn

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.

Shanghai Shen Lian Biomedical Corporation Fundamentals Summary

How do Shanghai Shen Lian Biomedical's earnings and revenue compare to its market cap?
688098 fundamental statistics
Market capCN¥1.69b
Earnings (TTM)CN¥13.44m
Revenue (TTM)CN¥307.69m

125.9x

P/E Ratio

5.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688098 income statement (TTM)
RevenueCN¥307.69m
Cost of RevenueCN¥99.67m
Gross ProfitCN¥208.02m
Other ExpensesCN¥194.58m
EarningsCN¥13.44m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 30, 2024

Earnings per share (EPS)0.033
Gross Margin67.61%
Net Profit Margin4.37%
Debt/Equity Ratio0%

How did 688098 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

91%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.